癌症患者PCI术后90天内急性心肌梗死与出血再入院分析
活动性癌症患者AMI再入院率(全癌9.1%)和出血再入院率(全癌1.6%)均高于无癌症患者(分别为5.6%和0.6%),风险幅度因癌症类型和转移状态而异。
要点
- 活动性癌症患者PCI术后90天AMI再入院率高于无癌症患者。
- 活动性癌症患者PCI术后90天出血再入院率高于无癌症患者。
- 再入院风险因癌症类型和是否存在转移而异。
核心结论
- PCI术后癌症患者因AMI或出血再入院的风险增加,风险幅度取决于癌症类型和转移状态。
主要发现
- 活动性癌症患者90天AMI再入院率:肺癌12.1%、结肠癌10.8%、乳腺癌7.5%、前列腺癌7.0%、全癌9.1%,无癌症患者为5.6%。
- 活动性癌症患者90天出血再入院率:结肠癌4.2%、肺癌1.5%、前列腺癌1.4%、乳腺癌0.6%、全癌1.6%,无癌症患者为0.6%。
- AMI再入院平均时间从肺癌26.7天至结肠癌30.5天,出血再入院平均时间从结肠癌38.2天至乳腺癌42.7天。
临床怎么用
- 对接受PCI的癌症患者应加强出院后90天内AMI和出血风险的监测与随访。
- 评估再入院风险时需考虑癌症类型及是否存在转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The post-discharge outcomes of patients with cancer who undergo PCI are not well understood. This study evaluates the rates of readmissions within 90 days for acute myocardial infarction (AMI) and bleeding among patients with cancer who undergo percutaneous coronary intervention (PCI). METHODS AND RESULTS: Patients treated with PCI in the years from 2010 to 2014 in the US Nationwide Readmission Database were evaluated for the influence of cancer on 90-day readmissions for AMI and bleeding. A total of 1 933 324 patients were included in the analysis (2.7% active cancer, 6.8% previous history of cancer). The 90-day readmission for AMI after PCI was higher in patients with active cancer (12.1% in lung, 10.8% in colon, 7.5% in breast, 7.0% in prostate, and 9.1% for all cancers) compared to 5.6% among patients with no cancer. The 90-day readmission for bleeding after PCI was higher in patients with active cancer (4.2% in colon, 1.5% in lung, 1.4% in prostate, 0.6% in breast, and 1.6% in all cancer) compared to 0.6% among patients with no cancer. The average time to AMI readmission ranged from 26.7 days for lung cancer to 30.5 days in colon cancer, while the average time to bleeding readmission had a higher range from 38.2 days in colon cancer to 42.7 days in breast cancer. CONCLUSIONS: Following PCI, patients with cancer have increased risk for readmissions for AMI or bleeding, with the magnitude of risk depending on both cancer type and the presence of metastasis.
引用
- Kwok CS, Wong CW, Kontopantelis E, et al. Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA. Eur Heart J. 2021. PMID: 33681960. doi:10.1093/eurheartj/ehaa1032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。